The following experimental evidence fostered this view: 1) KCa3.1-mRNA levels were 12-fold higher in ccRCC compared to the benign tumor, oncocytoma, and 2-fold higher than in healthy cortical tissue. This evidence concerns the gene KCNN4 and nonpapillary renal cell carcinoma.